Lyndra Therapeutics Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
82
- Latest Deal Type
-
Out of Business
Lyndra Therapeutics General Information
Description
Developer of novel therapeutics designed to sustain extended drug release in an oral dosage form. The company is engaged in the development of oral ultra-long-acting and sustained-release therapies for broad applicability across multiple therapeutic areas, including approved drugs, enabling the medical community to ensure improved medication adherence and health outcomes and helping lower the cost of care.
Contact Information
Website
www.lyndra.comCorporate Office
- 65 Grove Street
- Suite 301
- Watertown, MA 02472
- United States
Corporate Office
- 65 Grove Street
- Suite 301
- Watertown, MA 02472
- United States
Lyndra Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Out of Business | 25-Mar-2025 | Completed | Out of Business | |||
| 13. Later Stage VC (Series E) | 21-Dec-2023 | Completed | Clinical Trials - Phase 3 | |||
| 12. Later Stage VC (Series D) | 07-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 11. Secondary Transaction - Private | 03-May-2022 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC (Series C) | 23-Jun-2021 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 01-Jun-2021 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 01-Jan-2020 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 30-Sep-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 30-Jul-2019 | $13M | $84.4M | Completed | Startup | |
| 5. Early Stage VC (Series B) | 11-Feb-2019 | $60.9M | $84.4M | Completed | Clinical Trials - Phase 2 |
Lyndra Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 21,961,511 | $0.001000 | 6% | $1.08 | $1.08 | 1x | $1.08 | 17.28% |
Lyndra Therapeutics Comparisons
Industry
Financing
Details
Lyndra Therapeutics Competitors (14)
One of Lyndra Therapeutics’s 14 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Gilead Sciences | Formerly VC-backed | Foster City, CA | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Lyndra Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lyndra Therapeutics Patents
Lyndra Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240398701-A1 | Manufacturing methods for gastric residence systems | Pending | 02-Jun-2023 | ||
| AU-2023354428-A1 | Risperidone dosage regimens with gastric residence systems | Pending | 30-Sep-2022 | ||
| EP-4565274-A2 | Metal cores for gastric residence systems | Pending | 03-Aug-2022 | ||
| AU-2023209872-A1 | Dosage forms for gastric retention | Pending | 19-Jan-2022 | ||
| EP-4465964-A2 | Dosage forms for gastric retention | Pending | 19-Jan-2022 | A61K9/0065 |
Lyndra Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lyndra Therapeutics Investments (1)
Lyndra Therapeutics’s most recent deal was a Joint Venture with Lyndra (China) Pharmaceuticals Company. The deal was made on 01-May-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Lyndra (China) Pharmaceuticals Company | 01-May-2018 | Joint Venture | Pharmaceuticals |
Lyndra Therapeutics FAQs
-
When was Lyndra Therapeutics founded?
Lyndra Therapeutics was founded in 2015.
-
Where is Lyndra Therapeutics headquartered?
Lyndra Therapeutics is headquartered in Watertown, MA.
-
What is the size of Lyndra Therapeutics?
Lyndra Therapeutics has 82 total employees.
-
What industry is Lyndra Therapeutics in?
Lyndra Therapeutics’s primary industry is Drug Discovery.
-
Is Lyndra Therapeutics a private or public company?
Lyndra Therapeutics is a Private company.
-
What is Lyndra Therapeutics’s current revenue?
The current revenue for Lyndra Therapeutics is .
-
How much funding has Lyndra Therapeutics raised over time?
Lyndra Therapeutics has raised $288M.
-
Who are Lyndra Therapeutics’s competitors?
Pfizer Manufacturing Austria, ACADIA Pharmaceuticals, Intas Pharmaceuticals, Gilead Sciences, and Pfizer Pakistan are some of the 14 competitors of Lyndra Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
